Related Experiment Video
Updated: Apr 16, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis]
Mai Mishima1, Masanori Makita, Yasuhisa Sando
1Department of Internal Medicine, Suita Municipal Hospital.
Abstract:
Paraneoplastic inflammation of the large vessels is a rare complication of myelodysplastic syndrome (MDS), and patients with MDS and systemic vasculitis have a poor prognosis. We present a 66-year-old male with MDS and large vessel vasculitis treated with azacitidine. Azacitidine administration improved his clinical symptoms, high fever and thickening of the arterial wall, and he achieved a complete bone marrow remission. However, 1 year later he showed progression of MDS. For MDS with vasculitis, intensive therapy, the same as that given to the high-risk group, should be considered and azacitidine administration may represent an efficacious treatment.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
